Literature DB >> 24427671

Could cellular proliferation be a predictive index for the relapse of nasal polyposis and down-regulated by nasal steroid treatment?

Ilter Tezer1, Ozlem Celebi Erdivanli2, Arif Sanli3, Sedat Aydin3.   

Abstract

The aim of this article is to identify the cellular mitotic activity using Ki-67 monoclonal antibody for predicting relapses of nasal polyposis after surgery. A prospective study was conducted at Kartal Training and Research Hospital Otolaryngology Department between January 2006 and September 2008. Nasal polyps were obtained from all patients and pathological materials were analyzed for the Ki-67 staining using immunohistochemistry. Patients were followed after surgery for 12 months for relapse. There was no statistically significant difference between recurrent and nonrecurrent polyps. Polyp recurrence has a multifactorial origin. Ki-67 index alone does not provide sufficient information about polyp recurrence before the operation.

Entities:  

Keywords:  Cellular proliferation; Nasal polyposis; Nasal steroid treatment

Year:  2012        PMID: 24427671      PMCID: PMC3738774          DOI: 10.1007/s12070-012-0485-x

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  14 in total

1.  Inflammatory cells in nasal mucosa and nasal polyps.

Authors:  S Morinaka; H Nakamura
Journal:  Auris Nasus Larynx       Date:  2000-01       Impact factor: 1.863

2.  Nasal polyposis pathogenesis: a flow cytometric and immunohistochemical study of epithelial cell proliferation.

Authors:  A Coste; J G Rateau; J F Bernaudin; R Peynègre; E Escudier
Journal:  Acta Otolaryngol       Date:  1996-09       Impact factor: 1.494

3.  Long-term follow-up of cellular proliferation as a predictive index for the relapse of nasal polyposis.

Authors:  Ernesto Bruno; Ehab I Mohamed; Marco Alessandrini; Sabino Russo; Stefania Schiaroli; Antonino De Lorenzo; Alberto Di Girolamo
Journal:  Am J Rhinol       Date:  2002 Sep-Oct

4.  Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.

Authors:  Margriet A Huisman; Emile De Heer; Jan J Grote
Journal:  Acta Otolaryngol       Date:  2003-04       Impact factor: 1.494

5.  [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].

Authors:  Yu Xu; Zhanyuan Wu; Zezhang Tao; Qingquan Hua; Kangye Jin
Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi       Date:  2003-01

6.  Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps.

Authors:  B Petruson; H A Hansson; K Petruson
Journal:  Acta Otolaryngol       Date:  1988 Jul-Aug       Impact factor: 1.494

7.  Increased epithelial cell proliferation in nasal polyps.

Authors:  Ming-Che Hsu; Chia-Tung Shun; Chia-Ming Liu
Journal:  J Formos Med Assoc       Date:  2002-03       Impact factor: 3.282

8.  Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.

Authors:  Mariusz Koda; Stanislaw Sulkowski; Luiza Kanczuga-Koda; Eva Surmacz; Mariola Sulkowska
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

9.  Increased epithelial cell proliferation in nasal polyps.

Authors:  A Coste; J G Rateau; F Roudot-Thoraval; C Chapelin; L Gilain; F Poron; R Peynegre; J F Bernaudin; E Escudier
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-04

10.  Predictive value of the fraction of cancer cells immunolabeled for proliferating cell nuclear antigen or Ki67 in biopsies of head and neck carcinomas to identify lymph node metastasis: comparison with clinical and radiologic examinations.

Authors:  Ming Liu; Georges Lawson; Monique Delos; Jacques Jamart; Christophe Ide; Emmanuel Coche; Birgit Weynand; Gauthier Desuter; Marc Hamoir; Marc Remacle; Etienne Marbaix
Journal:  Head Neck       Date:  2003-04       Impact factor: 3.147

View more
  1 in total

1.  A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis.

Authors:  Giuseppe Brescia; Gino Marioni; Sebastiano Franchella; Giulia Ramacciotti; Luciano Giacomelli; Filippo Marino; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-13       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.